175 related articles for article (PubMed ID: 32063065)
1. Economic vulnerability and payment for research participation.
Gelinas L; White SA; Bierer BE
Clin Trials; 2020 Jun; 17(3):264-272. PubMed ID: 32063065
[TBL] [Abstract][Full Text] [Related]
2. Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward.
Largent EA; Fernandez Lynch H
Yale J Health Policy Law Ethics; 2017; 17(1):61-141. PubMed ID: 29249912
[TBL] [Abstract][Full Text] [Related]
3. The limitations of "vulnerability" as a protection for human research participants.
Levine C; Faden R; Grady C; Hammerschmidt D; Eckenwiler L; Sugarman J;
Am J Bioeth; 2004; 4(3):44-9. PubMed ID: 16192138
[TBL] [Abstract][Full Text] [Related]
4. Truth in Advertising: Disclosure of Participant Payment in Research Recruitment Materials.
Gelinas L; Lynch HF; Largent EA; Shachar C; Cohen IG; Bierer BE
Ther Innov Regul Sci; 2018 May; 52(3):268-274. PubMed ID: 29714586
[TBL] [Abstract][Full Text] [Related]
5. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Asch DA
Arch Intern Med; 2004 Apr; 164(7):801-3. PubMed ID: 15078651
[TBL] [Abstract][Full Text] [Related]
6. Payment of research subjects for more than minimal risk trials is unethical.
Wong JC; Bernstein M
Am J Med Sci; 2011 Oct; 342(4):294-6. PubMed ID: 21804364
[TBL] [Abstract][Full Text] [Related]
7. The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.
Welch MJ; Lally R; Miller JE; Pittman S; Brodsky L; Caplan AL; Uhlenbrauck G; Louzao DM; Fischer JH; Wilfond B
Clin Trials; 2015 Oct; 12(5):503-10. PubMed ID: 26374681
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials of drugs and vaccines among the desperately poor in poor nations: ethical challenges and ethical solutions.
Caplan AL
Clin Pharmacol Ther; 2010 Nov; 88(5):583-4. PubMed ID: 20959841
[TBL] [Abstract][Full Text] [Related]
9. The everyday ethics of field work research with vulnerable patients.
Lichtner V
Stud Health Technol Inform; 2014; 205():813-7. PubMed ID: 25160300
[TBL] [Abstract][Full Text] [Related]
10. Financial remuneration for clinical and behavioral research participation: ethical and practical considerations.
Permuth-Wey J; Borenstein AR
Ann Epidemiol; 2009 Apr; 19(4):280-5. PubMed ID: 19230712
[TBL] [Abstract][Full Text] [Related]
11. Research participation as work: comparing the perspectives of researchers and economically marginalized populations.
Davidson P; Page K
Am J Public Health; 2012 Jul; 102(7):1254-9. PubMed ID: 22594754
[TBL] [Abstract][Full Text] [Related]
12. The Challenges of Research Informed Consent in Socio-Economically Vulnerable Populations: A Viewpoint From the Democratic Republic of Congo.
Kalabuanga M; Ravinetto R; Maketa V; Muhindo Mavoko H; Fungula B; Inocêncio da Luz R; Van Geertruyden JP; Lutumba P
Dev World Bioeth; 2016 Aug; 16(2):64-9. PubMed ID: 26346178
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical research involving the homeless.
Beauchamp TL; Jennings B; Kinney ED; Levine RJ
J Med Philos; 2002 Oct; 27(5):547-64. PubMed ID: 12461710
[TBL] [Abstract][Full Text] [Related]
14. Paying Participants in COVID-19 Trials.
Largent EA; Lynch HF
J Infect Dis; 2020 Jul; 222(3):356-361. PubMed ID: 32469074
[TBL] [Abstract][Full Text] [Related]
15. Clinical research: protection of the "vulnerable"?
Park SS; Grayson MH
J Allergy Clin Immunol; 2008 May; 121(5):1103-7. PubMed ID: 18313131
[TBL] [Abstract][Full Text] [Related]
16. Payments to children and adolescents enrolled in research: a pilot study.
Iltis AS; DeVader S; Matsuo H
Pediatrics; 2006 Oct; 118(4):1546-52. PubMed ID: 17015545
[TBL] [Abstract][Full Text] [Related]
17. Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials: a proposal.
Ndebele P; Mfutso-Bengo J; Mduluza T
Malawi Med J; 2008 Jun; 20(2):42-5. PubMed ID: 19537431
[TBL] [Abstract][Full Text] [Related]
18. Misconceptions about coercion and undue influence: reflections on the views of IRB members.
Largent E; Grady C; Miller FG; Wertheimer A
Bioethics; 2013 Nov; 27(9):500-7. PubMed ID: 22493972
[TBL] [Abstract][Full Text] [Related]
19. Microbicide research in developing countries: have we given the ethical concerns due consideration?
Moodley K
BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
[TBL] [Abstract][Full Text] [Related]
20. Payment of clinical research subjects.
Grady C
J Clin Invest; 2005 Jul; 115(7):1681-7. PubMed ID: 16007244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
